BioCatalystWatch
UNCYWorkspace / UNCY / OverviewCompany library
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc. (UNCY)

Website

Price
Market cap
Next catalystFDA PDUFA target action date: March 25, 2027; any shorter review remains conditional on cGMP findings and FDA alignment.Oxylanthanum carbonate (OLC) — hyperphosphatemia on dialysis · Regulatory decisionCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

History / paused

SUR2B (mitochondrial KATP channel)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status
1M1M

Market Reaction / Supply Context

Market Structure

UNCY PR & News

PR & News

UNCY SEC archive